$7.32
Today
as of Jul 22, 16:48 ET
Last 30 days
Recent Press Releases & News
Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Strength Seen in Precision BioSciences (DTIL): Can Its 12.3% Jump Turn into More Strength?
Precision BioSciences Joins Russell 2000 Index
Overview
52-week range
$3.53
$8.82
72% of range
Avg surprise (last 3)
-902.2%
Avg reaction (last 2)
-5.2%
0% positive
Latest IV / EM
85%
EM ±19.5% · $8 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue May 5, 2026 | Mar/2026 | $-0.34 | $-0.27 | -25.9% | +84.6% | -2.4% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-1.84 | — | — | — | — | financials |
| Thu Aug 7, 2025 | Jun/2025 | $-2.13 | $-0.09 | -2,267% | — | — | earnings |
| Thu May 15, 2025 | Mar/2025 | $-2.21 | $-0.43 | -413.9% | — | -8.1% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-2.25 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $4.67 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $1.70 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-2.10 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-3.13 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Aug 6, 2026 | Jun/2026 | OTHER | -$0.71 | -$2.13 | +66.7% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-9M | — | $-21M | $-22M | $-22M | — | $-21M | $24M |
| Net income | $-18M | — | $-22M | $-24M | $-21M | — | $-16M | $33M |
| EPS (diluted) | $-0.75 | — | $-1.84 | $-2.13 | $-2.21 | — | $-2.25 | $4.67 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $99M | $111M | $45M | $62M | $77M | $86M | $99M | $124M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $109M | $119M | $52M | $70M | $82M | $95M | $111M | $144M |
| Total assets | $144M | $154M | $94M | $109M | $124M | $136M | $153M | $166M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $68M | $62M | $77M | $75M | $75M | $80M | $88M | $91M |
| Total equity | $76M | $92M | $17M | $34M | $49M | $56M | $65M | $75M |